Barrett's esophagus market seen reaching $9.52 billion by 2030

The Barrett's esophagus market is forecast to grow from $6.71 billion in 2025 to $9.52 billion by 2030, driven by wider use of advanced endoscopic imaging, precision ablation therapies and earlier intervention. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The market is expanding as Barrett's esophagus care becomes more closely tied to earlier detection and cancer prevention. - Rising demand for diagnostics and treatment reflects the growing clinical burden of gastroesophageal reflux disease and the risk of progression to esophageal cancer. - The forecast points to more spending on endoscopic procedures, outpatient care and specialty gastroenterology services.

What happened: - The Business Research Company said the global Barrett's esophagus market is projected to rise from $6.71 billion in 2025 to $7.17 billion in 2026. - The report forecasts the market will reach $9.52 billion by 2030, implying a 7.3% CAGR from 2026 to 2030. - The company released its Barrett's Esophagus Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report is available as a free sample.

The details: - Barrett's esophagus is a condition in which acid reflux damages the normal lining of the esophagus. - The affected tissue becomes thicker and reddish in color. - The cells in Barrett's esophagus are more resistant to stomach acid than typical squamous cells. - The condition is diagnosed more often in men than in women. - Barrett's esophagus is more prevalent among white populations. - Historical market growth came from higher GERD prevalence, greater awareness of esophageal cancer risk, broader access to endoscopic diagnostics, growth in gastroenterology specialty services and better clinical monitoring protocols. - Future growth is expected to come from advanced endoscopic imaging, broader use of precision ablation therapies, stronger emphasis on early intervention, more outpatient endoscopic procedures and continued research to prevent disease progression. - Esophageal cancer risk is higher in patients with Barrett's esophagus with dysplasia. - High-grade dysplasia carries the greatest risk of progression to esophageal cancer. - The American Cancer Society said about 21,560 people in the U.S. were expected to be diagnosed with esophageal cancer in 2023, up from 20,640 in 2022. - The full report is available here.

Between the lines: - The report's growth outlook suggests the market is becoming more procedure-driven, with technology and intervention timing shaping demand. - Cancer-risk management appears to be a central driver, which can support sustained demand for screening, surveillance and treatment. - North America remained the largest regional market in 2025, while Asia-Pacific is projected to be the fastest-growing region. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

What's next: - The Business Research Company says its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspots infographics, and updated graphics and tables. - Ongoing adoption of advanced endoscopic tools and precision therapies is likely to shape the next phase of market growth. - Asia-Pacific's faster growth trajectory may narrow the gap with established markets over time.

The bottom line: - Barrett's esophagus is moving from a niche clinical segment toward a larger prevention- and procedure-focused market, with growth tied to cancer risk, diagnostic technology and early treatment.